Cannara Biotech Inc (LOVE) - Cash Flow Conversion Efficiency

Latest as of November 2025: 0.072x

Based on the latest financial reports, Cannara Biotech Inc (LOVE) has a cash flow conversion efficiency ratio of 0.072x as of November 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$7.96 Million ≈ $5.76 Million USD) by net assets (CA$111.21 Million ≈ $80.45 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see LOVE market cap for the company's overall valuation and market capitalisation.

Cannara Biotech Inc - Cash Flow Conversion Efficiency Trend (2018–2025)

This chart illustrates how Cannara Biotech Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Cannara Biotech Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Cannara Biotech Inc ranked by their cash flow conversion efficiency. Explore LOVE cash flow quality score to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
City Lodge Hotels Ltd JSE:CLH	0.194x
OFX Group Ltd AU:OFX	0.923x
Clal Industries and Beverages Ltd TA:CLBV	-0.001x
DR.Wu Skincare Co Ltd TWO:6523	0.022x
HMA AGRO INDUSTRIES ORD (BSE) NSE:HMAAGRO	0.033x
ENIGMATIG LIMITED NYSE MKT:EGG	0.008x
Moens Bank A/S CO:MNBA	N/A
Grigeo AB STU:WM8	0.060x

Annual Cash Flow Conversion Efficiency for Cannara Biotech Inc (2018–2025)

The table below shows the annual cash flow conversion efficiency of Cannara Biotech Inc from 2018 to 2025. View today's stock price for Cannara Biotech Inc for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-08-31	CA$102.22 Million ≈ $73.95 Million	CA$20.01 Million ≈ $14.48 Million	0.196x	+61.19%
2024-08-31	CA$87.95 Million ≈ $63.62 Million	CA$10.68 Million ≈ $7.73 Million	0.121x	+63.86%
2023-08-31	CA$79.74 Million ≈ $57.69 Million	CA$5.91 Million ≈ $4.28 Million	0.074x	+181.38%
2022-08-31	CA$66.74 Million ≈ $48.28 Million	CA$-6.08 Million ≈ $-4.40 Million	-0.091x	-179.05%
2021-08-31	CA$64.12 Million ≈ $46.38 Million	CA$-2.09 Million ≈ $-1.51 Million	-0.033x	+86.57%
2020-08-31	CA$38.36 Million ≈ $27.75 Million	CA$-9.32 Million ≈ $-6.75 Million	-0.243x	-63.78%
2019-08-31	CA$49.93 Million ≈ $36.12 Million	CA$-7.41 Million ≈ $-5.36 Million	-0.148x	+5.07%
2018-08-31	CA$14.74 Million ≈ $10.66 Million	CA$-2.30 Million ≈ $-1.67 Million	-0.156x	--

About Cannara Biotech Inc

V:LOVE Canada Drug Manufacturers - Specialty & Generic

Market Cap

$126.80 Million

CA$175.28 Million CAD

Market Cap Rank

#18380 Global

#610 in Canada

Share Price

CA$1.83

Change (1 day)

-2.14%

52-Week Range

CA$1.58 - CA$1.98

All Time High

CA$3.05